This is the first time the NDRC has fined a device maker, according to the report.
The China Economic Herald — the official publication of the NDRC — said Medtronic is just the “tip of the iceberg,” claiming the regulatory body is monitoring 100 other drug companies and device makers.
According to WSJ, a Medtronic spokesperson said the company accepted the decision and plans to pay the fine.
More articles on supply chain:
Survey: 48% of U.S. manufacturers list unqualified workers as largest barrier to growth
Opinion: Why supply chain execs must take the lead in stopping climate change
Express Scripts stock tumbles 9% after short-seller’s ‘take-down’ tweet
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
